The role of non-invasive cardiovascular imaging in the assessment of cardiovascular risk in rheumatoid arthritis: where we are and where we need to be

Autor: Graham J. Fent, Sven Plein, Maya H Buch, John P Greenwood
Rok vydání: 2016
Předmět:
Carotid Artery Diseases
Computed Tomography Angiography
Arthritis
Rheumatoid/epidemiology

Heart Valve Diseases
Coronary Artery Disease
Disease
030204 cardiovascular system & hematology
Carotid Intima-Media Thickness
Arthritis
Rheumatoid

Ventricular Dysfunction
Left

0302 clinical medicine
Immunology and Allergy
Medicine
Ultrasonography
Computed tomography angiography
education.field_of_study
medicine.diagnostic_test
Vascular Calcification/diagnostic imaging
Cardiovascular Diseases/diagnostic imaging
Magnetic Resonance Imaging
Cardiovascular Diseases
Echocardiography
Heart Valve Diseases/diagnostic imaging
Rheumatoid arthritis
Ventricular Dysfunction
Left/diagnostic imaging

Risk assessment
Algorithms
Coronary Artery Disease/diagnostic imaging
medicine.medical_specialty
Immunology
Population
Risk Assessment
General Biochemistry
Genetics and Molecular Biology

Decision Support Techniques
03 medical and health sciences
Vascular Stiffness
Rheumatology
Humans
In patient
Carotid Artery Diseases/diagnostic imaging
Vascular Calcification
education
Intensive care medicine
030203 arthritis & rheumatology
Atherosclerosis/diagnostic imaging
business.industry
Non invasive
Magnetic resonance imaging
Atherosclerosis
medicine.disease
Positron-Emission Tomography
Physical therapy
Tomography
X-Ray Computed

business
Zdroj: Fent, G J, Greenwood, J P, Plein, S & Buch, M H 2017, ' The role of non-invasive cardiovascular imaging in the assessment of cardiovascular risk in rheumatoid arthritis : where we are and where we need to be ', Annals of the rheumatic diseases, vol. 76, no. 7, pp. 1169-1175 . https://doi.org/10.1136/annrheumdis-2016-209744
ISSN: 1468-2060
0003-4967
Popis: This review assesses the risk assessment of cardiovascular disease (CVD) in rheumatoid arthritis (RA) and how non-invasive imaging modalities may improve risk stratification in future. RA is common and patients are at greater risk of CVD than the general population. Cardiovascular (CV) risk stratification is recommended in European guidelines for patients at high and very high CV risk in order to commence preventative therapy. Ideally, such an assessment should be carried out immediately after diagnosis and as part of ongoing long-term patient care in order to improve patient outcomes. The risk profile in RA is different from the general population and is not well estimated using conventional clinical CVD risk algorithms, particularly in patients estimated as intermediate CVD risk. Non-invasive imaging techniques may therefore play an important role in improving risk assessment. However, there are currently very limited prognostic data specific to patients with RA to guide clinicians in risk stratification using these imaging techniques. RA is associated with increased risk of CV mortality, mainly attributable to atherosclerotic disease, though in addition, RA is associated with many other disease processes which further contribute to increased CV mortality. There is reasonable evidence for using carotid ultrasound in patients estimated to be at intermediate risk of CV mortality using clinical CVD risk algorithms. Newer imaging techniques such as cardiovascular magnetic resonance and CT offer the potential to improve risk stratification further; however, longitudinal data with hard CVD outcomes are currently lacking.
Databáze: OpenAIRE